Inferensys

Guide

Setting Up an AI Validation Pipeline for Regulatory-Grade Genomics

A step-by-step technical guide to building an automated, reproducible validation pipeline for AI models in clinical genomics, ensuring compliance with FDA SaMD and other regulatory frameworks.
Governance lead reviewing model governance framework on laptop, policy documents visible, executive office setup.
GUIDE OVERVIEW

Introduction

This guide establishes a rigorous pipeline for validating AI-based genomic tests intended for clinical use, ensuring they meet regulatory standards for accuracy and reproducibility.

Regulatory-grade genomics demands more than high model accuracy; it requires a validation pipeline that proves an AI system is safe, effective, and traceable. This framework aligns with FDA SaMD principles and clinical guidelines like CLIA, transforming research code into auditable medical software. The pipeline's core components are a curated truth set of known variants, automated testing suites, and comprehensive reporting for submission.

You will implement this pipeline by first defining performance metrics (sensitivity, specificity, PPV) against a gold-standard dataset. Next, you'll automate testing with a tool like Nextflow or Snakemake to ensure reproducibility across compute environments. Finally, you'll generate audit trails and reports that document every model decision, creating the evidence needed for regulatory review and clinical trust.

METRICS COMPARISON

Key Validation Metrics for Genomic AI Tasks

Essential performance and compliance metrics for validating AI models in clinical genomics, aligned with FDA SaMD principles.

MetricDiagnostic Variant CallingPolygenic Risk ScoringVariant Pathogenicity Prediction

Sensitivity (Recall)

99.5%

95%

90%

Specificity / Precision

99.9%

98%

85%

Analytical Validity (vs. GIAB)

Clinical Validity (vs. ClinVar)

Area Under the ROC Curve (AUC-ROC)

0.999

0.85

0.95

Positive Predictive Value (PPV)

99.5%

80%

75%

Reproducibility (Inter-run CV)

< 0.5%

< 2%

< 1%

Bias Audit (across ancestries)

Mean Absolute Error (MAE)

< 0.05

Explainability Score (0-1)

0.8

0.7

0.9

TROUBLESHOOTING

Common Mistakes

Building a validation pipeline for regulatory-grade genomics is complex. These are the most frequent technical pitfalls developers encounter and how to fix them.

Your pipeline is likely using a truth set that lacks diversity. A common mistake is validating only against high-confidence, common variants from reference datasets like Genome in a Bottle (GIAB). For regulatory-grade validation, you must include:

  • Rare and complex variants (large indels, structural variants)
  • Variants in low-complexity regions and segmental duplications
  • Samples from diverse ancestries to avoid population bias

Fix: Curate a comprehensive truth set that mirrors the real-world genomic landscape your test will encounter. Use a mix of orthogonal validation technologies (e.g., long-read sequencing, Sanger) to establish ground truth for challenging regions. This aligns with FDA SaMD guidance for demonstrating clinical validity across intended use populations.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.